Video: German cannabis legalisation and potential tailwinds ahead of 2022
German medical cannabis legalisation and potential tailwinds ahead of 2022
What effect would a German Cannabis legalisation have on the broader European landscape?
This is one of the many questions Florian Berberich (Associate Director DACH at Rize ETF) asked John Kagia, (Chief Knowledge Officer at New Frontier Data and thematic research partner of Rize ETF), during their 20-minute conversation.
Furthermore, they also discussed topics like the development of the European cannabis landscape, the difference between the adult-use and Medical Cannabis market, and the requirements to run a successful liberal cannabis policy in which both industries exist alongside each other.
—
Introduction
(2:45) What is the difference between the adult-use and medical cannabis market?
(6:25) What are the tailwinds that can be observed in the medical space coming from a legislation of adult use cannabis?
(12:14) What is the European landscape looking like?
(15:40) What does it take to run a liberal cannabis policy that has both a medical and an adult-use market?
(20:05) What is the market outlook for Germany?
Related ETF
